NattoPharma

NattoPharma is a Norwegian company that has the exclusive global sales and marketing rights to MenaQ7™, a form of natural vitamin K2 (menaquinone 7) derived from the traditional Japanese food natto. MenaQ7™ is most biologically active vitamin K2 available and is supported by extensive clinical research relating to bone and cardiovascular health.

NattoPharma is investing extensively in research and development, and development of intellectual property relating to natural vitamin K2 and has entered into an exclusive alliance with the leading vitamin K expert group in the world, VitaK BV, at the Cardiovascular Research Institute, University of Maastricht, in the Netherlands. This, combined with a strategic partnership with Sumitomo Corporation in Japan makes NattoPharma the world leader in natural vitamin K2.

MenaQ7™ is available in either oily or powder forms for use in complementary medicines and functional foods.